Tert-butyl N-[1-[3-[(3-chloro-2-methoxy-4-pyridinyl)sulfanyl]-1H-pyrazolo[3,4-b]pyrazin-6-yl]-4-methylpiperidin-4-yl]carbamate;tert-butyl N-[4-methyl-1-(3-sulfanylidene-1,2-dihydropyrazolo[3,4-b]pyrazin-6-yl)piperidin-4-yl]carbamate;1-[7-[(3-chloro-2-methoxy-4-pyridinyl)sulfanyl]-5H-pyrrolo[3,4-b]pyrazin-3-yl]-4-methylpiperidin-4-amine;oxane
C66H93Cl2N19O8S3 — CID 159569915
Data last refreshed: (MolForge compound catalog, from PubChem)
About Tert-butyl N-[1-[3-[(3-chloro-2-methoxy-4-pyridinyl)sulfanyl]-1H-pyrazolo[3,4-b]pyrazin-6-yl]-4-methylpiperidin-4-yl]carbamate;tert-butyl N-[4-methyl-1-(3-sulfanylidene-1,2-dihydropyrazolo[3,4-b]pyrazin-6-yl)piperidin-4-yl]carbamate;1-[7-[(3-chloro-2-methoxy-4-pyridinyl)sulfanyl]-5H-pyrrolo[3,4-b]pyrazin-3-yl]-4-methylpiperidin-4-amine;oxane
Tert-butyl N-[1-[3-[(3-chloro-2-methoxy-4-pyridinyl)sulfanyl]-1H-pyrazolo[3,4-b]pyrazin-6-yl]-4-methylpiperidin-4-yl]carbamate;tert-butyl N-[4-methyl-1-(3-sulfanylidene-1,2-dihydropyrazolo[3,4-b]pyrazin-6-yl)piperidin-4-yl]carbamate;1-[7-[(3-chloro-2-methoxy-4-pyridinyl)sulfanyl]-5H-pyrrolo[3,4-b]pyrazin-3-yl]-4-methylpiperidin-4-amine;oxane (PubChem CID 159569915) has the molecular formula C66H93Cl2N19O8S3 and a molecular weight of 1447.70 g/mol. Its IUPAC name is tert-butyl N-[1-[3-[(3-chloro-2-methoxy-4-pyridinyl)sulfanyl]-1H-pyrazolo[3,4-b]pyrazin-6-yl]-4-methylpiperidin-4-yl]carbamate;tert-butyl N-[4-methyl-1-(3-sulfanylidene-1,2-dihydropyrazolo[3,4-b]pyrazin-6-yl)piperidin-4-yl]carbamate;1-[7-[(3-chloro-2-methoxy-4-pyridinyl)sulfanyl]-5H-pyrrolo[3,4-b]pyrazin-3-yl]-4-methylpiperidin-4-amine;oxane.
Molecular Properties
| Compound Name | Tert-butyl N-[1-[3-[(3-chloro-2-methoxy-4-pyridinyl)sulfanyl]-1H-pyrazolo[3,4-b]pyrazin-6-yl]-4-methylpiperidin-4-yl]carbamate;tert-butyl N-[4-methyl-1-(3-sulfanylidene-1,2-dihydropyrazolo[3,4-b]pyrazin-6-yl)piperidin-4-yl]carbamate;1-[7-[(3-chloro-2-methoxy-4-pyridinyl)sulfanyl]-5H-pyrrolo[3,4-b]pyrazin-3-yl]-4-methylpiperidin-4-amine;oxane |
|---|---|
| PubChem CID | 159569915 |
| Molecular Formula | C66H93Cl2N19O8S3 |
| Molecular Weight | 1447.70 g/mol |
| Exact Mass | 1445.60 |
| IUPAC Name | tert-butyl N-[1-[3-[(3-chloro-2-methoxy-4-pyridinyl)sulfanyl]-1H-pyrazolo[3,4-b]pyrazin-6-yl]-4-methylpiperidin-4-yl]carbamate;tert-butyl N-[4-methyl-1-(3-sulfanylidene-1,2-dihydropyrazolo[3,4-b]pyrazin-6-yl)piperidin-4-yl]carbamate;1-[7-[(3-chloro-2-methoxy-4-pyridinyl)sulfanyl]-5H-pyrrolo[3,4-b]pyrazin-3-yl]-4-methylpiperidin-4-amine;oxane |
| SMILES | C1CCOCC1.C1CCOCC1.CC1(NC(=O)OC(C)(C)C)CCN(c2cnc3c(=S)[nH][nH]c3n2)CC1.COc1nccc(SC2=NCc3nc(N4CCC(C)(N)CC4)cnc32)c1Cl.COc1nccc(Sc2n[nH]c3nc(N4CCC(C)(NC(=O)OC(C)(C)C)CC4)cnc23)c1Cl |
| InChI | InChI=1S/C22H28ClN7O3S.C18H21ClN6OS.C16H24N6O2S.2C5H10O/c1-21(2,3)33-20(31)27-22(4)7-10-30(11-8-22)14-12-25-16-17(26-14)28-29-19(16)34-13-6-9-24-18(32-5)15(13)23;1-18(20)4-7-25(8-5-18)13-10-22-15-11(24-13)9-23-17(15)27-12-3-6-21-16(26-2)14(12)19;1-15(2,3)24-14(23)19-16(4)5-7-22(8-6-16)10-9-17-11-12(18-10)20-21-13(11)25;2*1-2-4-6-5-3-1/h6,9,12H,7-8,10-11H2,1-5H3,(H,27,31)(H,26,28,29);3,6,10H,4-5,7-9,20H2,1-2H3;9H,5-8H2,1-4H3,(H,19,23)(H2,18,20,21,25);2*1-5H2 |
| InChIKey | MHRKMGXQGDURSK-UHFFFAOYSA-N |
| XLogP | 12.62 |
| TPSA | 325.06 Ų |
| H-Bond Donors | 6 |
| H-Bond Acceptors | 25 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 98 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1447.70 |
| LogP ≤ 5 | 12.62 |
| H-Bond Donors ≤ 5 | 6 |
| H-Bond Acceptors ≤ 10 | 25 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Thiocarbonyl_group', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159569915 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.